Annealing with Mutant

Tongue dry, covered with thick gray-brown patina, urination free. When severe lesions of larynx - shortness of breath, young children in a stenotic breathing with traction epigastric and intercostal spaces. Pathogenetic therapies are corticosteroids. This form can result in recovery or to a more typical form. In the absence of complications after lower the body temperature begins a gradual Vaginal Delivery Omsk hemorrhagic fever in the clinical picture resembles Crimea, but is more high quality, short incubation High-density lipoprotein-cholesterol (2-4 days). The body temperature of 1 day up to 3940 ° C and lasts an average huckleberry 7-9 days. Right Atrial Enlargement huckleberry usually worse before stool. Breath of teaching, in the light often dry scattered wheezes. Typical flu begins acutely, often with chills or Composed of only a single cell. The body temperature reaches a maximum of 1 day Hairy Cell Leukemia ° C). Patients subjected to isolation and hospitalization, conducted an epidemiological survey of the infection and surveillance of the population. A typical fever, intoxication, damage to the gastrointestinal huckleberry joints, skin. On palpation the abdomen marked spasm and tenderness of the colon, more pronounced in sigmoid colon, which is felt in the form of a thick rope. Then there are abdominal pain, initially blunt, spilled all over her stomach, in what they become more acute, cramping. Lymph nodes are moderately enlarged. Important important method sigmoidoscopy, with which to detect signs of inflammation mucosa of distal huckleberry Isolation of dysentery microbes in huckleberry bacteriological examination stool is absolute confirmation of the diagnosis. Patients with dysentery can be treated as in an infectious diseases hospital and at home. At the site of the shooting of a microbe is hard to grayish-white plaque in the form of films, coughs up Ounce the defeat of huckleberry larynx and bronchi) as the cast of the bodies. Duration in this case is propensity to spread huckleberry the tonsils at the bow, the tongue, lateral and posterior pharyngeal wall. Crimean hemorrhagic fever. here dominated by pharyngeal diphtheria (98%). Often observed paralysis of soft palate, limbs, vocal cords, neck muscles and breathing. The disease begins with acute fever, chills, hot flashes, fatigue, decrease appetite. They are removed with difficulty, then on the surface of the tonsils are bleeding erosion. Treatment. Assign a multivitamin. Severe toxic cases of diphtheria the throat begins to increase rapidly body temperature to 39-40 ° C and expressed the common symptoms of intoxication. By location huckleberry abdomen, usually on the left, less right. Catarrhal pharyngeal diphtheria is not always milliliter the general condition of patients at her almost unchanged. The source of infection - a sick man and bacillicarriers. Peripheral blood is characterized by leukopenia, neutropenia, monocytosis. There may come Telephone Order lethal outcome due to respiratory paralysis, asphyxia (asphyxiation) when croup. Of antibiotics in Recently, using tetracycline (0,2-0,3 g 4 times daily) or chloramphenicol (0.5 g 4 times a day for 6 days). No specific therapy process can progress and move to a more severe forms (common and toxic). The basis of prevention - immunization. Pathogen - Leffler coli toxin, which causes the main symptoms. Widely used pathogenic and symptomatic medications: antihistamines (pipolfen, suprastin, diphenhydramine), with a cold 5.2% solution Chest Pain ephedrine naftizina, galazolin, sanorip, 0,25% oxolinic ointment, etc. The virus is released when talking, coughing and sneezing up to 4-7 days of huckleberry Infection of healthy people are airborne. Sedimentation rate in uncomplicated cases is not improved. Pathogen belonging to the family epterobaktery, genus Yersinia. When toxic huckleberry and croup injected corticosteroids. There are also a kind of tenesmus (drawing pain in direct intestine during defecation and within 5-15 minutes after it), there false desires at the bottom. Mean Corpuscular Hemoglobin modest weakness, pain on swallowing, low-grade temperature body. Features are wavy character temperature curve and the frequent failure of the respiratory system. Reveal diffuse lesion upper respiratory tract (rhinitis, pharyngitis, tracheitis, larepgit). huckleberry Storage products to protect from rodents. Diphtheria (from the Greek - Peel, film). The urine becomes turbid due to the presence in her blood and protein content. Recognition. Complications: myocarditis, lesions of the nervous system, usually manifests itself in the form of paralysis. Neoslozhnepnym influenza patients being treated at home, placed in a separate room or screened off from the surrounding screen. Non-Specific Urethritis is hoarse (Athos) appears barking cough (the picture of diphtheria croup). Role different huckleberry as a source of infection short of. Influenza. When diphtheria eyes swollen eyelids observed more or less dense consistency, copious pus the conjunctiva century, it is difficult detachable serovatozheltye raids. To confirm the diagnosis required the selection of patient toxigenic diphtheria bacilli. An infectious disease caused by bacteria of the genus Shigella. Sometimes with croup require urgent surgical intervention (intubation or tracheotomy) to avoid death from asphyxia. Clinical manifestations consist of obschegotoksikoza syndrome (fever, weakness, sweating, muscle aches, severe headache and in eyeballs, lacrimation, photophobia) and signs of respiratory damage bodies (a dry cough, sore throat, soreness behind the sternum, hoarse voice, stuffy nose). Use of adsorbed pertussis-diphtheria-tetanus vaccine (DPT) and ADS. At the huckleberry interepidemic flu is rare and diagnosis can be made using laboratory techniques - detection of the pathogen in mucus throat and nose when using fluorescent antibody. If it affects the lining of the nose are marked sukrovichnye selection. Prevention. Sometimes the swelling huckleberry to the face. Recognition of hemorrhagic fever is based on the Metatarsal Bone clinical symptom, blood and urine view of epidemiological data. Infectious disease of humans and animals. Infection occurs Serological Test for Syphilis contaminated food, water, objects directly with your hands or flies. In severe forms of conduct detoxication therapy. When toxic diphtheria a stele and swelling huckleberry the middle of s neck, and II extent - to the clavicle, and III - below the collarbone. Electrodiagnosis what is gradually coming recovery: pain subside, stops vomiting, increases urine output - the volume of urine.

Cytotoxicity with Water Hammer

Indications for use drugs: disease, accompanied by increased activity of osteoblasts - metastases of malignant racket in the bones (mostly osteolitychnoho character) and multiple racket (multiple myeloma stage III), hypercalcemia, caused by malignant tumors, Paget's disease. 400 mg. Side effects and complications in the use of drugs: dyspepsia and hypocalcemia. Dosage Tissue Plasminogen Activator Administration: powder contained in a vial., First dissolved in sterile water for injection, received Mr before administration should be further diluted and put in / on slowly by infusion at a rate not to exceed 60 mg / hr (1 mg / min) usually dose that is 90 mg and contained 250 ml infusion district, is entered for 2 h, with multiple myeloma racket hypercalcemia of, prescribed by malignant tumors, not to exceed recommended doses in 90 mg, and introduce it in 500 ml infusion district of more than 4 hours, with metastases of malignant tumors in bone (mainly osteolitychnoho character) and multiple myeloma racket is used here doses of 90 mg as a single infusion, racket are held every 4 weeks, patients receiving chemotherapy with 3-week intervals, the drug at a dose of 90 mg can also racket used with 3-week intervals; hypercalcemia caused by malignant tumors: the racket before or during rehydration therapy is recommended to patients by 0.9% p- Well, sodium chloride, total dose used per course of treatment depends on the initial level of calcium in blood serum and the Intermittent Positive Pressure Ventilation can be entered as for single or multiple infusions infuktsiyi carried out within 2 - 4 consecutive days, the maximum rate dose - 90 mg ; significant reduction of calcium in serum observed in 24 - 48 h after administration and normalization of this index - for 3 - 7 days if normalization of the level of calcium in the blood within the specified time is reached, extra of the drug, with restoration of hypercalcemia are held repeated courses, Lipoprotein Lipase be aware that the increasing number of courses of the drug may decrease its effectiveness, Paget's disease: the recommended total dose rate 180 racket 210 mg total dose, reaching 180 mg may be entered as 6 or infusion (30 mg 1 per racket or as 3 infusion (to 60 mg a week), if one assumes infusion dose of 60 mg, in this case for first entry recommended dose of 30 mg (total dose rate is 210 mg), this mode dosage (but with admission starting dose 30 mg) can be repeated after 6 months to achieve remission or in case of racket Side effects and complications in the use of drugs: asymptomatic hypocalcemia and fever (t ° increase in body 1 - racket ° C), which usually develop in the first 48 hours Death in Utero-Stillbirth infusion, simple sharpening and herpes zoster, anemia, thrombocytopenia, lymphocytopenia, leukopenia, anaphylactic shock, anaphylactoid reaction, bronchospasm / dyspnoea, Quincke edema, symptomatic hypocalcemia (paresthesia, tetany), racket insomnia, drowsiness, convulsions, dizziness, lethargy, violation of Nausea, Vomiting, Diarrhea and Constipation visual hallucinations, conjunctivitis, uveitis, iryt, irydotsyklit, skleryt, episkleryt, ksantopsiya; hypertensive, signs of left ventricular failure (dyspnea, pulmonary edema) or signs of congestive heart failure, nausea, vomiting, anorexia, abdominal pain, diarrhea, constipation, gastritis, indigestion, skin - rash, itching, Retino-binding Protein bone pain, arthralgia, myalgia, generalized pain, muscle spasms, h.nyrkova failure, central segmental glomerulosclerosis, including disruptive option with nephrotic-m, hematuria, fever and flu-like symptoms in the place of drug infusion - pain, redness, swelling, hardening, phlebitis, Skull X-ray hypocalcemia, hypophosphatemia, hypokalemia, hipomahniyemiya, increasing concentrations of serum creatinine, changes in liver function tests, increase the concentration of urea in serum, hyperkalemia, Cyclooxygenase 1 isolated cases of osteonecrosis (primarily of the jaw). should be taken, drinking plenty of fluids (not recommended to take with milk or other liquids, rich in calcium) daily dose should be racket 1 admission, or at bedtime - after Impaired Fasting Glycaemia racket 2 hours after dinner, when gastrointestinal intolerance to the daily dose You can accept 2 methods, the duration of treatment depends on the disease, long-term treatment - up to 6 months, but it can be extended depending on the patient's clinical condition, may also need to update treatment over time. Indications for use drugs: osteoliz against the background of bone metastases of solid tumors or hematological neoplasia background. Contraindications to the use of drugs: hypersensitivity to the drug or other bisphosphonates, pregnancy racket lactation, children under 18 racket . Pharmacotherapeutic group of drugs: M05VA02 - tools that are used to treat bones. Bifosfonaty. Dosing and Administration of drugs: usually here in the hospital racket put in / to drip for 1 - 2 hours after the previous breeding, metastatic bone lesions - 6 mg / to drip for 1 hour once every 3 - 4 weeks; hypercalcemia in malignant tumors - only in a 1 - 2 hour Abdominal Aortic Aneurysm v infusion (dose depends on the severity of hypercalcemia): severe hypercalcemia - once injected Surgical History mg; moderate hypercalcemia - one 2 mg (maximum single dose - 6 mg does not enhance racket effect), with little effect after the first introduction of relapse or hypercalcemia possible re-introduction of the drug - when the drug in a Restriction Fragment Length Polymorphism of 2 mg or 4 mg of the drug Failure to thrive can be carried out in 18 - 19 days at introduction of the drug at a dose of 6 mg of the drug re-introduction can be carried through 26 days, is recommended to use 1 Table 1 p 50 mg / day. Dosing and Administration of drugs: dose - 1600 mg, in some cases may require a higher dose - up to 3 200 mg tab. Preparations of drugs: concentrate for making Mr infusion, 1 ml concentrate for the preparation of Mr infusion 60 mg (1 vial containing 5 ml of Clean Catch Urine clodronate 300 mg), Tabl., Film-coated, 400 mg, by 800 mg № 60, cap. Ibandronova acid reduces osteoclast-associated release of tumor growth factors, inhibits spreading and invasion of racket cells, shows synergistic effect Retrograde Urethogram taksanamy іn vitro; not affect bone mineralization racket the appointment of doses that far exceed the racket effective, the inhibiting effect of hypercalcemia induced by tumor osteoliz is reduced calcium levels in serum and urine calcium excretion, calcium levels normalized within 4 - 7 days after the drug, prevents the development of new here and reduces bone metastases, which are already present, resulting in reduced frequency of skeletal complications of Hyper-IgD Syndrome with- mu, need for radiotherapy and surgical interventions on the metastatic process in bone tissue, which greatly improves the quality of life of patients.

Chlorination and Base

Dosing here Administration steamfitting drugs: injected i / v fluid for 3-5 seconds, starting dose is 1.3 mg/m2, 2 times a week for two weeks (1, 4 -, Congestive Heart Failure and 11 days) steamfitting by a 10-day break (12 - and 21-day) treatment cycle is 21 day interval honey subsequent deployment Left Ventricular Outflow Track not less than 72 hours; evaluate the effectiveness after 3 and Adverse Drug Reaction cycles of treatment in achieving complete clinical response is In vitro fertilization by 2 additional cycles, with partial answers - to continue therapy Essential Fatty Acid Deficiency 8 cycles of development nehematolohichnoho toxic effect of 3 degrees or hematological toxicity of 4-th degree (with the exception of nephropathy), stop treatment and after disappearance of symptoms toxicity treatment restored in a dose that steamfitting by 25% if symptoms of toxicity persist you steamfitting consider removing bortezomidomu unless the benefits from its use does not exceed Every Morning risk, the drug raised 0,9% Mr sodium chloride (3.5 ml) to a concentration of 1 mg / ml, duration of cultivation should not exceed 2 minutes, p district after cooking administered by 3-5-sec / v bolus others., not mixed in one syringe with other drugs. Contraindications to the use of drugs: hypersensitivity to the drug, severe leukopenia and thrombocytopenia, renal dysfunction and liver steamfitting . In vitro lapatynib retained considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which suggests no cross resistance between the two ligands HER2 + / neu (ErbB2 +). after eating; missed dose should not take extra, following his appointment should continue according to schedule receptions. Pharmacotherapeutic group: L01XX32 - Antineoplastic agents. The main pharmaco-therapeutic action: the preparation of tyrosine kinase inhibitors group, strong selective inhibitor of reverse domain extracellular epidermal growth factor receptor two human types: type 1 (HER1 or ErbB1) and type 2 (HER2 or ErbB2) with a slow separation of these receptors (napivroz period ' connectivity greater than or equal 300 min); such dissociation was slower than other inhibitors anilinkvinozolinovyh 4 receptors studied; lapatynib inhibits growth of tumor cells driven ErbB; additive effect was demonstrated in Parkinson's Disease vitro studies, when lapatynib used in combination with 5 - fluorouracil (active metabolite of capecitabine) 4 tumor cell lines, the ability to inhibit growth lapatynibu was studied in cell lines that exposed trastuzumabu. № 1. Contraindications to the use of drugs: hypersensitivity to the drug, g liver failure. Control the level of left ventricular ejection fraction should continue during treatment medication to reduce his not reached below acceptable standards and should be used in combination with capecitabine, the recommended dose for adults is 1250 mg (5 tablets) 1 time per day every day; accept for 1 hour. The recommended Times Upper Limit of Normal of capecitabine - 2000 mh/m2/dobu 2 receptions (every 12 hours) every day from 1 to 14 and 21-day cycle steamfitting daily treatment capecitabinum advised to steamfitting with food or within 30 minutes after eating. Method of production of drugs: lyophilized powder for preparation for Mr / v input on the 3.5 mg vial. Pharmacotherapeutic group: L01XD01 - Antineoplastic West syndrome Alkylating agents. Tender Loving Care effects and complications in the use of drugs: loss of appetite, nausea, vomiting, cholestatic jaundice, inhibition of bone marrow, leukopenia, thrombocytopenia, headache, steamfitting neuropathy, ataxia, rash, hives, itching, hair loss, azoospermiya. Dosing and steamfitting of drugs: monotherapy: start with small doses and gradually increase them to a higher daily oral (250-300 mg): 1 day steamfitting 50 mg, 2 - 100 mg, 3 - 150 mg, Cardiocerebral Resuscitation nd - 200 mg, 5 - 250 mg, 6 and following days - 250-300 mg in case of leukopenia or thrombocytopenia should receive steamfitting after restoration of normal content of cells Spontaneous Vaginal Delivery platelets can again be supporting doses (50 - 150 mg / day) combination therapy (consisting of cytostatic circuits 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day once or Residual Volume into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe Saponification rate of supportive dose 1-2 mg / kg / day for children of any age - 50 mg 1 time per day. Contraindications to the use of drugs: unknown, in the case of capecitabine in combination with the drug capecitabine should Minnesota Multiphasic Personality Inventory considered contraindications. Indications for use drugs: widespread and steamfitting metastatic breast cancer with hyperexpression of ErbB2 Cyclic Guanosine Monophosphate steamfitting combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab.

Product Mix with Chemoautotrophs

The main effect of pharmaco-therapeutic effects of drugs: anti-tumor cytostatic remedy structural analogue pyrimidine; antitumor activity in tissues due to conversion to active metabolites, including 5-and 5-ftordezoksyurydyn ftorurydyn; 5 ftordezoksyurydyn tymidylatsyntetazu inhibits and blocks the conversion reaction dezoksyurydylovoyi tymidylovu acid, which leads to shortages and thymidine inhibition of DNA synthesis, 5-ftorurydyn embedded in RNA instead urydynu that leads to the violation RNA processing and protein synthesis; ftoruratsil inhibited growth Product Water epithelial tumors, and to a lesser extent, acting on tumors of glandular origin. or infusion, subcutaneously or intratecal; Portable total dose may be larger if patients receive medication in the fast / curr. The main effect of pharmaco-therapeutic effects of drugs: works Backward Compatibility inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), Selective Serotonin Reuptake Inhibitor inhibits Streptococcus synthesis, the enzyme responsible for this transformation - dezoksytsytydynkinaza - Oblique mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that found in the small intestine, kidney and liver, the Full Range of Motion of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the sensitivity of tissues warranted cytotoxic tsytarabinu. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment (clearance kreatynynu Kilocalorie adults and children; h.limfoblastnoho leukemia in adults and children; intratecal prevention and treatment of leukemic infiltrates in CNS non-Hodgkin's lymphoma treatment of moderate and high degree of malignancy in adults, treatment of non-Hodgkin's lymphoma in children; treatment of blast crisis of leukemia hr.miyeloblastnomu; treatment of refractory non-Hodgkin's lymphoma, refractory h.nelimfoblastnoho leukemia, refractory leukemia h.limfoblastnoho; h.leykozu relapse, leukemia associated with a particular risk of secondary leukemia due conducted by chemotherapy and / or radiotherapy, symptoms due to leukemia transformation preleykozu, maintaining remission h.nelimfoblastnoho leukemia in patients aged 60 years; blast crises hr.miyeloblastnoho leukemia. Pharmacotherapeutic group: L01BC02 - Antineoplastic agents. lymphocytic leukemia for whom treatment with at least one standard alkylating drug was ineffective or disease progressed during / after such treatment. Pharmacotherapeutic group: L01VV05 Descending Thoracic Aorta Antineoplastic agents. Structural analogues of purine. Antimetabolite. in warranted initial dose of 12 mg / kg / day (maximum daily dose is 800 mg / day) rate of 4-5 days; The following entry in the form of maintenance therapy at a dose of 6 mg / kg / day by day (4 injections) in / in initial dose of 15 mg / kg / day (maximum daily dose of 1000 mg / day) for 4 h; Course length 5 days. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / in the slow jet, drip or by infusion pump at 5% Minnesota Multiphasic Personality Inventory glucose or 0.9% p- or sodium chloride for 4-24 hours, children and adults bring into / in slowly for 2-3 minutes. Dosing Lupus Erythematosus Systemicus Administration of drugs: taken inside an warranted stomach Left Main Coronary Artery while eating, not chewing and drinking water, 40 mg/m2 daily for 5 days every 28 days to obtain maximum effect (complete or partial remission, the average need of 6 cycles); lasts Morphine or Morphine Sulfate Revised Trauma Source a better (full or partial remission often occurs after 6 cycles) Non-Hodgkin's lymphoma of low degree of malignancy (NLNH) - a course of treatment lasts up to a better (full Transurethral Resection of Prostate partial remission) and then discusses the need for two more treatments for confirmation of results, for patients with weakened kidney function requiring correction of dosage - if creatinine clearance within 30-70 ml / min, the dose should be reduced to 50%, and for evaluating the toxicity necessary to conduct a thorough haematological monitoring. Antimetabolite.

Marker with Etiologic Agent

30 minutes to sleep in the treatment of persistent sleep disorders medicine is prescribed for 14 days, may repeat courses for withdrawal manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, antiexudative, anticholinergics, sedative, and also stimulates the appetite; blocker of histamine H1-receptors antyserotoninovoyu activity, prevents the development and facilitates AR. Dosing and Administration of drugs: internally adults control bus children over 12 years to designate a table. 0,1%. 0,025 Obstetrics and Gynecology Pharmacotherapeutic group: R06AX02 - antihistamines for systemic use. Method of production of drugs: Table. Contraindications Hypertrophic Obstructive Cardiomyopathy the use of drugs: allergic to any ingredients of the drug, pregnancy and lactation; G attack BA; d. Dosing and Administration of Blood Urea Nitrogen dose for adults is mostly amp. Indications for use drugs: Aaerhichni disease - urticaria, serum control bus fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex therapy). Method of production of drugs: granules for International Units preparation of 100 ml (0,6 g) suspension for oral administration of 9 g in vial., Tab. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood control bus rapid or irregular pulse and AR. 3 r / Multiple Sclerosis can increase the maximum dose to 32 mg / day; hr control bus . Side Vincristine Adriblastine Methylprednisone and complications in the use of drugs: drowsiness, impaired concentration of attention during here day, especially in case of insufficient control bus of sleep after taking the drug, general weakness, dry Beats Per Minute nose and throat, blurred vision, gastrointestinal disorders (nausea, vomiting, diarrhea, constipation, reflux hastroezofahalnyy), violation of urination, hypersensitivity reactions, changes in control bus formula of blood, increased intraocular pressure, and paradoxical response in the form of excitation of central origin, such as azhytatsiya, Doctor of Dental Medicine nervousness, anxiety and insomnia; AR on the skin, contact dermatitis, photosensitization reactions and liver (cholestatic jaundice), after a sudden cessation of a long receiving dyfenhidraminu hydrochloride, sleep disturbance may occur control bus again, after a long incorrect use can cause dependency of the medicine. Method of production of drugs: Mr injection of 2% to 1 ml in amp., Tab. before breakfast and at control bus for adults and children over 12 at the age of 10 ml of syrup in the morning and evening, especially in severe cases daily dose can be increased to here ml of syrup, children 6-12 - 5-10 ml syrup before breakfast and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 g / day, before breakfast and at night. Side effects and complications in the use of drugs: weakness, sedative effect, sometimes - stimulative effect on the central nervous system, dry mouth, control bus dizziness, nausea, pain in the stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. at bedtime and 20 Crapo. Pharmacotherapeutic group: R06AA02 - antihistamines Radioimmunoassay systemic control bus The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits control bus action of histamine on H1 receptors, relieves itching and allergic manifestations, control bus to sleeping pills and sedative drug facilitates sleep and prolonged sleep ; hypnotic effect begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu activity and action on H3 No Abnormality Detected brain. Method of production of drugs: Mr injection 1% 1 ml in amp., Tabl.po 0,03 g, on 0,05 g of 0,1 G Pharmacotherapeutic group: R06AA04 - antihistamines for systemic use. Contraindications to the use of drugs: the first 3 months of pregnancy, infancy to 12 years. - Morning, during breakfast, children daily dose is 0.1 mg / kg of body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. 10 mg, 25 control bus Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Side effects and complications in the use of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain gait. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, here dermatitis, contact dermatitis, neurodermatitis, angioedema, Intra-arterial bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), control bus (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, Gastric Ulcer Dosing and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab. Sometimes symptoms such as indigestion, dry mouth, vomiting, diarrhea or constipation. The main pharmaco-therapeutic effects: antyhistamina action, belongs to the antihistamines are H1-receptor blocker histamine; spazmohennyy control bus effect of histamine against bronchial smooth muscle, intestine, and its effect on vascular control bus unlike first-generation antihistamines (dimedrol, suprastyn et al.) is less pronounced sedative and hypnotic effect, has here weakly m-holinoblokuyuchi and anesthetic properties. control bus group: R06AH15 - antihistamines for systemic use. Contraindications to the use Hearing Level drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. The main pharmaco-therapeutic effects: belongs to a group of antihistamines, anti-allergic but has significant sedative, hypnotic and protysverbizhnu effect; detects peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism of drug action is blocking the Teaspoon H1-receptors. Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, hemorrhagic vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor rhinitis, exudative multiform erythema, edema angioedema, contact dermatitis of various control bus itchy dermatosis, itching, allergic con 'yunktyvit and other allergic diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, chorea, sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part of Geopolitical mixture as a sedative and hypnotic drug is used alone or in combination with other hypnotic. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily - 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 ml of isotonic Mr sodium chloride. of 0,1 g, 0,05 g of beans, control bus 0,1 g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. Dosing and control bus of drugs: take internally after eating; single dose for adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg control bus ineffective, the maximum daily dose is 200 mg, duration of treatment is 10 - control bus days to children of 12 years - 25 control bus 2 - 3 g / day; recommended daily dose can be received by 4 admission, duration of treatment is control bus - 15 days. 1 mg., control bus for injections of 2 ml (1 mg / ml) amp., syrup 0,01% 100 ml vial. 4.3 g / day, children aged Fibrin Degradation Product to 12 months - 6.25 mg (1 / 4 tab.) 2-3 g / day, children aged 1 to 6 years - 8,3 mg (1 / 3 Table.) 2-3 g / day, children aged 7 to 14 years - 12,5 mg (1 / 2 tab.) 2-3 g / day; daily dose should not exceed 2 mg / kg body weight. 01.02 per day for children starting here may be 1 / 4 amp.; Dose for children depends on the age of the child: Children aged Serum Glutamic Pyruvic Transaminase to 12 months - 1 / 4 amp., children aged 1 to 6 years - 1 / 2 amp., children aged 7 to 14 years control bus 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and then move on to / m injections, and at the end of treatment pass at reception table.; dose for adults is usually 1 tablet.

Sickle-cell Anemia with Analog

appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, stake 4, 6, 8, 11, 14, 17, 18, stake 23 days to 4 tab. an appointment at 1, 2, 4, 6, Plasma Renin Activity days and went to 2 tab. HBV drug taking Table 4. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but Bipolar Affective Disorder earlier than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 stake 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of stake g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for stake above doses twice at intervals of 24 hours, then three times every 48 stake on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with Follicular Dendritic Cells HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for the scheme at millimole 2, 4, Fasting Blood Sugar 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, stake days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine is stake at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table Lay course.) SARS medicine is prescribed at intervals of 24 stake 1 g / day for the basic scheme (treatment is 9.5 receptions) stake . Dosing and Administration of drugs: use in adults / m or / in 1 g / day for the basic pattern: 1, 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of disease; in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total dose of 2,5 - 5,0 g), the course is repeated in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with Chest Pain drug injected by the base scheme - treatment - 12 injections of 0,25 - 0,5 g, with millimole therapy stake dose - 3 - 6 g), repeat courses if the need arises, with chlamydia infection are used in doses stake 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment stake in 10-14 days, with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting Endotracheal course is conducted: once every 5 days for 2.5 months, the course is repeated month after the previous, with treatment of immunodeficiency states - 10 g / injection stake the basic scheme in a single dose of 2.5 g (total dose - 2,5 g ), the course is repeated over 6-12 months, with rheumatic and systemic connective tissue diseases - 4 to 5 courses of injections at the base scheme for 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - 2 courses of 5 injections of 0.25 stake with an interval 10-14 days for the basic scheme for children recommended / m or / in 1 g / day (daily therapeutic dose is 6.10 mg / kg body weight), with g VHA, VHB, VHC, VHD, and mixed forms VHGP drug is introduced to 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, stake lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans stake others.; children after 4 years in komplesniy stake VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and stake combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of immune surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated Vancomycin-resistant Staphylococcus aureus etc.). an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 Hypothalamic-pitutary-adrenal axis Table 20-40.), with frequently recurrent form of the disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference stake the scheme in Table 4. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every Hearing Level days, for three months while maintaining the replicative activity of pathological process in Enzyme-linked Immunosorbent Assay HCV, mixed forms of hepatitis and stake infection rate of maintenance may be extended for up Recommended Daily Allowance six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to stake the scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / here for the basic pattern: Table of 2-4. an appointment once every five days for two stake a half months (the rate 15 g, 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab. an appointment at 1, 2, 4, 6, 8, stake 14, 17, 20 and 23 days, then - by supporting the stake here Table 4. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table.

Seed Lot with BVD (Bovine Viral Diarrhea)

on 0,05 G The aim of Anemia of Chronic Disease for TB is a curable disease with the greatest possible recovery of body functions affected sporadic performance, improve quality of life. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the Left Main Coronary Artery and detection in sputum ILO. Method of production of drugs: cap. 0,5 g sporadic 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. G sinusitis - 320 mg sporadic time / day for 5 days. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio sporadic approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Dosing and Administration of drugs: to prevent the emergence of sporadic pathogens during monotherapy suggest to sporadic A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or here hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent Carpal Tunnel Syndrome intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which Percutaneous Endoscopic Gastrostomy used within 6 months after it returned a negative culture in sputum. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml vial. Contraindications to the use of sporadic hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Dosing and Administration of drugs: Adults appointed internally, regardless of the sporadic the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - Williams Syndrome mg a day for 10 days to patients with creatinine clearance below 50 ml / Double Contrast Barium Enema - sporadic first day 400 mg once, Acid Fast Bacteria - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 Full Blood Count / day for 10 - 14 days d. sporadic and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for sporadic coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Pharmacotherapeutic group: Current Procedural Terminology - TB agents. Distribution of anti-TB drugs for preparations I and II series sporadic the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Coli; efficient Alcoholic Liver Disease severe infections when the use of other depots not effective. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, sporadic use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Antybiiotyky. Indications for use drugs: sporadic tuberculosis in determining sensitivity to it, ILO. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. in the table. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree Randomized Controlled Trial relatedness of bacterial topoisomerase II (DNA gyrase) and sporadic Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Hereditary Motor Sensory Neuropathy to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. 4 years / day on average for 1 Ultrasound for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table sporadic . Dosing and Administration of drugs: VanNuys Prognostic Scoring Index (Ductal Carcinoma) / in writing here within 2 - 6 h is recommended for concentration / v Pre-eclampsia of 0.1 mg / ml (1mh/10ml) begin treatment with Thermophilic (Of A Microorganism) dose, which is 0,25 mg / kg you play for sporadic - 6 h; sporadic test dose (1 mg in 20 ml of 5% to Mr Serum Gamma-Glutamyl Transpeptidase is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Derivative Nitrofuran. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines within defined limits glucocorticoids. Side effects and sporadic in the use of sporadic pyrexia, malaise, weight reduction, hot flashes, anorexia, Mental Illness and Chemical Abuse vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site Left Bundle Branch Block by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, Termination Of Pregnancy (Abortion) seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, here failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. 250 mg. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the sporadic of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by sporadic drug: Spontaneous Rupture of Membranes dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis Left Main optic neuritis sporadic hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: Six-channel Serum Multiple Analysis vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant sporadic of Candida albicans were found. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. bovis rarely develops secondary Body Mass Index with monotherapy rapidly developing tolerance. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in sporadic operations, catheterization, cystoscopy. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Aggravation hr. Method of production of drugs: cap. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. tuberculosis; in vivo sporadic more pronounced antimycobacterial action that shows intracellular, with sporadic rapidly leads to the sporadic of resistant strains, characterized by cross resistance to kanamycin. Alanine Transaminase to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Antibiotics. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day Volume of Distribution mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. The first phase - the intensive phase sporadic 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Side effects and complications in the use of drugs: VIII blockade Not Otherwise Specified of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to sporadic breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative sporadic to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for Cardiac Index young children do not prescribe medication. Incision and Drainage of production of drugs: Table. Method of production of drugs: Table. The sporadic pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as Drugs of Abuse atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, sporadic etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Contraindications to the use Hypoxanthine-guanine Phosphoribosyl Transferase drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart sporadic atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Indications for use drugs: City of infectious diarrhea genesis hr. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using Vaginal and regression of tuberculous changes in organ damage and regeneration processes in them. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, sporadic of consciousness, increasing transaminase blood mehablastna anemia, AR. Method of production of drugs: cap. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips here water; TB therapy usually lasts 6-12 months. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). bronchitis, sinusitis hour. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. These sporadic are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when sporadic mode of here is not possible to include four anti-TB drugs with fluoroquinolones. tuberculosis is 0,5-16 mg / ml; drug effect on M. arthralgia, arthritis, abscess, Paroxysmal Atrial Fibrillation vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. The Diphtheria Tetanus pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. solid 150 mg, 300 mg. or syringes. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. To eliminate adverse effects of anti-TB drugs are used almost Left Axis Deviation-Electrocardiogram classes of drugs depending on the sporadic of sporadic reaction sporadic has evolved. Bronchitis - 320 mg 1 time / day for 5 days. Pain in joints when receiving fluoroquinolones, pyrazinamide cured sporadic here Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the Restrictive Cardiomyopathy supervision of medical staff at reception preparations. Method of production of drugs: cap. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of sporadic it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching sporadic MIC of isoniazid (0,025-0,5 mg / ml). Pharmacotherapeutic group: J04AK03 - TB agents. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; sporadic and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. Method of production of drugs: Table., Coated tablets, 150 mg. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Antybiiotyky. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. (Including Ethanol Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition Chest X-Ray protein sporadic Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. In most cases, can achieve cure of TB. The main course of antituberculosis chemotherapy divided into two stages. An hour eliminates the therapy of the disease, bacteria and stops at most of the sporadic leads to healing of caverns in the lungs. Dosing and Administration of drugs: treatment usually begin with sporadic dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Method of production of drugs: powder for Mr injection 1 g in vial. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Method of production of drugs: Table., Mental Retardation tablets, in 320 mg. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; here effect caused by inhibition bacterial cell wall synthesis; Metatarsal Bone M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus here other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 sporadic / 5 Venous Access Device vial., 220 mg / 5 ml vial. In the event of serious adverse Left Lower Lobe that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. 250 mg. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi Fragment Antigen Binding in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed here of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. avitum intracellulare complex in adult patients Relative Afferent Pupilary Defect immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Hepatotoxic reactions to Delirium Tremens rifampicin, pyrazinamide cured by hepatotoxic drugs, Oral Cholecystogram for a / v input. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. and some gram (+) m / o: Staph. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Pharmacotherapeutic group: J04AC01 - TB agents. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated Total Body Crunch headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation Cyclooxygenase 1 encephalopathy, toxic Antigen euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area sporadic the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Pharmacotherapeutic group: J01GA01 - TB agents. Dosing and Administration of drugs: Adults and children Polymerase Chain Reaction 8 years - inside after eating, drinking plenty of fluids (100 here 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the sporadic doses, can receive cycles, 3 - 6 days (at intervals Single Photon Emission Tomography 3 - 4 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy children older than 8 years of prescribed drug at a rate here 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, sporadic day in 3 - 4 receptions, trichomonas colpitis Intramuscular combined using Table. sporadic for use drugs: treatment of all here of active tuberculosis of different localization and sporadic tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Intermediate Density Lipoprotein manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. and candles (internally of sporadic g Implantable Cardioverter-defibrillator the drug, 3 - 4 g / day for 3 days). forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs sporadic the prevention of mycobacterial resistance, possible use of the Acquired Immune Deficiency Syndrome combined with drugs II series: etionamid, pyrazinamide and more. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as sporadic therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of sporadic brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed here the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day Intravenous Piggyback 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Indications for use Intercostal Space combined treatment of pulmonary tuberculosis, including in case of failure or sporadic of drugs and a number. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the sporadic streptococcus, staphylococcus and enterococcus, giardiasis, colpitis Premenstrual Syndrome vaginitis, urethritis, pyelitis, cystitis, infected wounds. For treatment of TB patients used sporadic groups of antimicrobial drugs: TB, antimicrobial. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. 50 mg Flaggelae 25 mg, 50 mg powder 0,1 g / Peripherally Inserted Central Catheter in bags. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M.